Medpace Holdings Inc
For the period ended Mar 31, 2024. Filed Apr 23, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 23, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the three months ended March 31, 2024, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
-25-
| Action | Date | Trading Arrangement | Total Shares to be Purchased or Sold | Duration/Expiration Date | ||
| Rule 10b5-1* | Non-Rule 10b5-1** | |||||
|---|---|---|---|---|---|---|
| Medpace Investors, LLC [1] | Adopt | February 16, 2024 [2] | X | Up to 50,000 shares to be sold | Good until cancelled | |
| Medpace Investors, LLC [1] | Adopt | February 20, 2024 [3] | X | Up to 50,000 shares to be sold | Good until cancelled | |
| Medpace Investors, LLC [1] | Adopt | February 22, 2024 [4] | X | Up to 100,000 shares to be sold | Good until cancelled | |
| Medpace Investors, LLC [1] | Adopt | February 23, 2024 [5] | X | Up to 156,928 shares to be sold | Good until cancelled | |
| Ashley M. Keating, Director | Adopt | February 26, 2024 [6] | X | Up to 1,972 shares to be sold | The earlier of until cancelled or 180 days from the placement of the limit order | |
| Medpace Investors, LLC [1] | Adopt | February 27, 2024 [7] | X | Up to 100,000 shares to be sold | Good until cancelled | |
| Medpace Investors, LLC [1] | Adopt | February 29, 2024 [8] | X | Up to 100,000 shares to be sold | Good until cancelled | |
| Medpace Investors, LLC [1] | Adopt | March 4, 2024 [9] | X | Up to 100,000 shares to be sold | Good until cancelled | |
| Jesse J. Geiger, President | Adopt | March 4, 2024 [10] | X | Up to 22,321 shares to be sold | March 4, 2024 | |
| Medpace Investors, LLC [1] | Adopt | March 6, 2024 [11] | X | Up to 100,000 shares to be sold | Good until cancelled | |
| Medpace Investors, LLC [1] | Adopt | March 7, 2024 [12] | X | Up to 100,000 shares to be sold | Good until cancelled | |
| Susan E. Burwig, Executive Vice President, Operations | Adopt | March 15, 2024 [13] | X | Up to 7,783 shares to be sold | March 15, 2024 | |
- Intended to satisfy the affirmative defense of Rule 10b5-1(c).
** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
[1]August J. Troendle, Chief Executive Officer and Chairman of the Board of the Company, is the sole manager and controlling unit holder of Medpace Investors, LLC (“MPI”) and has sole voting and investment control with respect to the securities held by MPI. Mr. Troendle may be deemed to indirectly beneficially own the securities of the Company held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
[2] On February 16, 2024, MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.
[3] On February 20, 2024, MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.
-26-
[4] On February 22, 2024, MPI placed a limit order to sell up to 100,000 shares that were previously acquired through open market purchases.
[5] On February 23, 2024, MPI placed a limit order to sell up to 156,928 shares that were previously acquired through open market purchases.
[6] On February 26, 2024, Ms. Keating placed multiple limit orders at multiple different prices to sell up to 1,972 shares issued to her pursuant to her contemporaneous exercise of stock options. On March 14, 2024, Ms. Keating cancelled her last sell order and executed a sell to cover trade.
[7] On February 27, 2024, MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.
[8] On February 29, 2024, MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.
[9] On March 4, 2024, MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.
[10] On March 4, 2024, Mr. Geiger placed a limit order to sell up to 22,321 shares issued to him pursuant to his contemporaneous exercise of stock options.
[11] On March 6, 2024, MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.
[12] On March 7, 2024, MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.
[13] On March 15, 2024, Ms. Burwig placed a limit order to sell up to 7,783 shares that were acquired upon the vesting of restricted shares.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.